Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 275 No 7357 p38
9 July 2005

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Warn about medicines that impair cognition, MP insists

Medicines that seriously impair cognitive function should be marked with a warning red triangle, according to Labour MP Andrew Dismore (Hendon).

Reintroducing a 10-minute rule Bill into the House of Commons this week, Mr Dismore said that warnings on medicines, such as benzodiazepine tranquillisers, antihistamines and tricyclic antidepressants were inadequate. Labelling was ambiguous and unhelpful and patients were unlikely to realise the actual level of drowsiness caused.

“ Those unclear or inadequate warnings could leave the drug manufacturer, prescribing doctor or dispensing pharmacist at risk of civil action for compensation for negligence if the patient suffers injury as a direct result of taking the medicines without fully appreciating the risks as a consequence of such a poor warning,” Mr Dismore told the House.

He added that red triangles were already used in Denmark, France, Iceland and Norway and that other symbols were used in Austria, Belgium, Italy and Spain.

“The UK is lagging behind continental Europe,” he said. “We should move towards a visible warning on those medicines that will leave no adult in any doubt about their potential effects.”

Mr Dismore’s Bill was first introduced during the previous Parliament, but fell when the general election was called (PJ, 5 February, p137). Ten-minute rule Bills rarely progress without Government support.

Back to Top


©The Pharmaceutical Journal